PSY

Defiance Next Gen Altered Experience ETF
*Unless otherwise stated, data provided by FactSet.

PSY Fund Description

PSY tracks a market-cap-weighted index of North American companies focused on psychedelics, medical cannabis, and ketamine for medicinal and health treatment purposes.

PSY Factset Analytics Insight

PSY is the first US-listed psychedelic ETF that seeks to track an index of publicly listed companies in North America that operate business models focused on the usage of psychedelics, medical cannabis, and ketamine for medicinal and health treatment purposes. Securities are required to have at least 50% of their revenue from legal activities related to medical psychedelics, medical cannabis, cannabis pharmaceuticals and cannabidiol derivatives, and ketamine. The index’s cap weighting provides limits that mitigate risk of overexposure to any single company. The fund could engage in securities lending of no more than one-third of its total asset value, which brings revenues to the fund at the cost of slight counterparty risk. The index is reconstituted and rebalanced semi-annually every March and September.

PERFORMANCE [as of 05/13/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
PSY -33.71% -49.46% -55.58% -- -- -- --
PSY (NAV) -35.07% -49.04% -55.08% -- -- -- --
No Underlying Index -- -- -- -- -- -- --
MSCI North America IMI / Pharmaceuticals Biotechnology & Life Sciences -IG -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

PSY Summary Data

Defiance ETFs
Defiance
05/27/21
Open-Ended Fund
0.75%
$4.50M
$120.90K
0.48%
N/A

PSY Portfolio Data

$852.95M
-2.25
1.46
--
N/A
19

PSY Index Data

No Underlying Index
Market Cap
Market Cap
MSCI North America IMI / Pharmaceuticals Biotechnology & Life Sciences -IG

PSY Portfolio Management

0.75%
--
--
--

PSY Tax Exposures

20.00% / 39.60%
--
Ordinary income
No

PSY Fund Structure

Open-Ended Fund
No
No
-- / --
N/A
N/A
High
Daily

PSY Factset Analytics Block Liquidity

As of 05/17/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of PSY. PSY is rated a 1 out of 5.

PSY Tradability

16,089
$120.90K
7,902
$51.29K
0.48%
$0.03
0.24%
3.60% / -1.13%
None
62.00%
50,000
0.16
0.05%
5.63%
319
$5.30
1

PSY Sector/Industry Breakdown


PSY
Segment Benchmark
45.17%
--
31.17%
--
7.81%
--
6.55%
--
6.54%
--
2.32%
--
0.54%
--
-0.09%
--

PSY Top 10 Holdings[View All]

10.73%
8.78%
7.65%
7.32%
4.87%
4.64%
4.51%
68.73%

PSY Countries


PSY
Segment Benchmark
50.43%
--
44.43%
--
5.14%
--

PSY Regions


PSY
Segment Benchmark
94.86%
--
5.14%
--

PSY Economic Development


PSY
Segment Benchmark
100.00%
--

PSY Performance Statistics

--
--
--
--
--
MSCI North America IMI / Pharmaceuticals Biotechnology & Life Sciences -IG

PSY Benchmark Comparison Holdings

19
--
--
--

PSY Benchmark Comparison Summary


PSY
Segment Benchmark
19
--
$852.95M
--
-2.25
--
1.46
--
0.21%
--
High
--

PSY Benchmark Comparison Market Cap Size


PSY
Segment Benchmark
0.00%
--
7.09%
--
28.12%
--
64.79%
--

Options Strategies for Outcome Investing

A collar strategy is a protective option strategy constructed by writing a call and buying a put with the same expiration date while being long the underlying security.